Author

Scott A. Hammond

AstraZeneca (United States)ORCID 0000-0001-5800-4328Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Adam Jacob SchoenfeldiD· 1 shared Ana Camelo Stewart· 1 shared Ben S. SiddersiD· 1 shared Bethany C. KennedyiD· 1 shared Caroline A.M. NordenvalliD· 1 shared Christian StockmanniD· 1 shared Christopher Andrew TibbittiD· 1 shared Claire WillisiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam Jacob SchoenfeldORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedMay 1, 2026

Pan-cancer analysis in the real-world setting uncovers immunogenomic drivers of acquired resistance post-immunotherapy

Mohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie…·Martin L. Miller

This study identifies immunogenomic drivers of acquired resistance to immunotherapy across multiple cancer types using a large-scale clinicogenomic dataset.

DOI 10.1136/jitc-2025-014321

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJan 24, 2024

Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers

Isaac Dean, Colin Y.C. Lee, Zewen Kelvin Tuong…·David R. Withers

This study shows that conventional NK cells rapidly lose effector functions upon entering tumors and that IL-15:IL-15Ra complexes can restore their function and tissue-residency.

210 citationstop 1%

mousehuman

𝕏 PostBluesky